377 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
into a debt financing facility providing the company with access to up to $400 million from funds managed by Oxford Finance LLC and Hercules Capital
8-K
EX-10.1
re9vbbzea 0g9k
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
k4j1r7q3s 5d8ynz3mn
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
zwybr7
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
s56kp20
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
S-3ASR
tniie818c
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-1.2
0lfunpx9px5b x5obf
30 Sep 22
Automatic shelf registration
4:17pm
425
3x524jljn 7u4aj5ipwk
24 Aug 22
Business combination disclosure
5:21pm
8-K
EX-99.1
khzwsrdyo ju51oyt
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
g56evgs2jn16la
21 Jun 22
Business combination disclosure
8:00am